California, USA-based biotech Prolynx, which is developing a next-generation portfolio of ultra-long-acting medicines for ...

Irish pharma manufacturer Gaelic Laboratories has acquired Athlone Laboratories, another Irish producer focused on oral dose ...

The European Medicines Agency has welcomed a political agreement between EU institutions on a far-reaching reform of ...

US biotech Amgen (Nasdaq: AMGN) has won approval from the US regulator for Uplizna (inebilizumab-cdon) to treat adults with ...

Disco Pharmaceuticals (DISCO) is headquartered in Cologne, Germany, with additional operations in Schlieren, Switzerland. The ...

Digital health stakeholders - including developers, policymakers, payers, and providers - are actively shaping and accelerating the adoption of digital health solutions, according to a new report from ...

Denmark’s Zealand Pharma and Chinese biotech OTR Therapeutics have announced a multi-program strategic collaboration and ...

US pharma major Bristol Myers Squibb has announced progress for its multi-indication cancer drug Opdivo (nivolumab) in ...

Switzerland-based Roivant hosted an Investor Day in New York City today, highlighting its leadership with key pipeline ...

Swiss clinical-stage biotech AC Immune today announced positive interim safety and efficacy results from the Phase II VacSYn ...

For decades, the generics industry has been dedicated to supporting the financial sustainability of health systems. By ...

Swiss pharma giant Roche (SIX: ROG) has announced positive data from the Phase III lidERA Breast Cancer study of giredestrant ...